Cellular Biologist Michael Mueckler Dies at 67

His work centered on the mechanisms of glucose transport into cells.

Written byLisa Winter
| 1 min read
M. Mueckler looking at the camera in front of his microscope in 1998.

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: Mueckler in his lab in 1998
BECKER MEDICAL LIBRARY, WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

Michael Mueckler, a cellular biologist who studied glucose transport and blood sugar regulation, has died at the age of 67. According to an announcement from the Washington University in St. Louis (WUSTL) School of Medicine, where Mueckler worked for more than 30 years, he died of natural causes in his home on July 14.

According to his WUSTL biography, Mueckler earned a bachelor’s degree in 1976 from the University of Wisconsin–Madison, and stayed there for his oncology PhD work. After graduating in 1983, he completed a three-year postdoc at MIT. He joined the faculty at WUSTL in 1986, where he remained until his retirement in 2019.

Mueckler’s work was centered around the mechanisms of glucose metabolism regulation and identifying factors that interfere with the process, leading to diabetes, certain cancers, and other conditions. For many years, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies